The market for tissue-engineered skin replacements and wound modulators is expected to reach nearly $1.9bn in 2024, a faster rebound than certain other elective procedures that can be put on hold, according to a new Meddevicetracker forecast. Global sales of tissue-engineered skin replacements and wound modulators are expected to rise at a compound annual growth rate (CAGR) of 7.0% percent, from $1.3bn in 2019.
However, as with other sectors in the medtech market, the COVID-19 pandemic has put a strain on several
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?